4 analysts have shared their evaluations of Transcat (NASDAQ:TRNS) during the recent three months, expressing a mix of bullish and bearish perspectives.
The table below provides a concise overview of recent ratings by analysts, offering insights into the changing sentiments over the past 30 days and drawing comparisons with the preceding months for a holistic perspective.
Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
---|---|---|---|---|---|
Total Ratings | 3 | 1 | 0 | 0 | 0 |
Last 30D | 1 | 0 | 0 | 0 | 0 |
1M Ago | 1 | 0 | 0 | 0 | 0 |
2M Ago | 0 | 0 | 0 | 0 | 0 |
3M Ago | 1 | 1 | 0 | 0 | 0 |
Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $157.0, a high estimate of $160.00, and a low estimate of $156.00. Marking an increase of 11.94%, the current average surpasses the previous average price target of $140.25.
Diving into Analyst Ratings: An In-Depth Exploration
The analysis of recent analyst actions sheds light on the perception of Transcat by financial experts. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.
Analyst | Analyst Firm | Action Taken | Rating | Current Price Target | Prior Price Target |
---|---|---|---|---|---|
Scott Buck | HC Wainwright & Co. | Maintains | Buy | $156.00 | $156.00 |
Scott Buck | HC Wainwright & Co. | Maintains | Buy | $156.00 | $156.00 |
Martin Yang | Oppenheimer | Raises | Outperform | $160.00 | $125.00 |
Scott Buck | HC Wainwright & Co. | Raises | Buy | $156.00 | $124.00 |
Key Insights:
- Action Taken: Analysts adapt their recommendations to changing market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their response to recent developments related to Transcat. This information provides a snapshot of how analysts perceive the current state of the company.
- Rating: Analyzing trends, analysts offer qualitative evaluations, ranging from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Transcat compared to the broader market.
- Price Targets: Analysts navigate through adjustments in price targets, providing estimates for Transcat's future value. Comparing current and prior targets offers insights into analysts' evolving expectations.
To gain a panoramic view of Transcat's market performance, explore these analyst evaluations alongside essential financial indicators. Stay informed and make judicious decisions using our Ratings Table.
Stay up to date on Transcat analyst ratings.
If you are interested in following small-cap stock news and performance you can start by tracking it here.
About Transcat
Transcat Inc is involved in providing calibration and laboratory instrument services and distribution of test, measurement, and control instrumentation. Its product and services portfolio consists of calibration instruments, dimensional measuring tools, Electrical test instruments, pressure measurement, etc. The firm has Service and Distribution operating segments. It derives the majority of its revenues from the Service segment. The firm promotes and sells its products under brand names such as Estech, FLIR, Fluke, Keysight, and Megger among others. It serves to pharmaceutical, industrial manufacturing, energy, and chemical process industries.
Transcat's Financial Performance
Market Capitalization Perspectives: The company's market capitalization falls below industry averages, signaling a relatively smaller size compared to peers. This positioning may be influenced by factors such as perceived growth potential or operational scale.
Revenue Growth: Over the 3 months period, Transcat showcased positive performance, achieving a revenue growth rate of 14.25% as of 31 March, 2024. This reflects a substantial increase in the company's top-line earnings. As compared to its peers, the company achieved a growth rate higher than the average among peers in Industrials sector.
Net Margin: Transcat's net margin is impressive, surpassing industry averages. With a net margin of 9.72%, the company demonstrates strong profitability and effective cost management.
Return on Equity (ROE): Transcat's ROE stands out, surpassing industry averages. With an impressive ROE of 3.11%, the company demonstrates effective use of equity capital and strong financial performance.
Return on Assets (ROA): Transcat's ROA surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 2.42% ROA, the company effectively utilizes its assets for optimal returns.
Debt Management: With a below-average debt-to-equity ratio of 0.1, Transcat adopts a prudent financial strategy, indicating a balanced approach to debt management.
Understanding the Relevance of Analyst Ratings
Ratings come from analysts, or specialists within banking and financial systems that report for specific stocks or defined sectors (typically once per quarter for each stock). Analysts usually derive their information from company conference calls and meetings, financial statements, and conversations with important insiders to reach their decisions.
Analysts may enhance their evaluations by incorporating forecasts for metrics like growth estimates, earnings, and revenue, delivering additional guidance to investors. It is vital to acknowledge that, although experts in stocks and sectors, analysts are human and express their opinions when providing insights.
This article was generated by Benzinga's automated content engine and reviewed by an editor.